Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials

Anesth Analg. 2010 Mar 1;110(3):659-62. doi: 10.1213/ANE.0b013e3181c85255.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anemia / blood
  • Anemia / mortality
  • Anemia / therapy*
  • Blood Substitutes / adverse effects
  • Blood Substitutes / therapeutic use*
  • Blood Transfusion
  • Compassionate Use Trials*
  • Contraindications
  • Drug Approval
  • Evidence-Based Medicine
  • Hemoglobins / adverse effects
  • Hemoglobins / therapeutic use*
  • Humans
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Treatment Refusal
  • United States
  • United States Food and Drug Administration

Substances

  • Blood Substitutes
  • Hemoglobins
  • HBOC 201